# Morgan Stanley share price today (Morgan Stanley, MS)

> Morgan Stanley's earnings have grown faster than its share price. Earnings per share grew +28.4% in a year while the price moved +13.5%. MS · Financials · Capital Markets · data as of 3 November 2026. Page: https://www.sectoralpha.in/us/stocks/ms

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Business trend: Growing steadily, from the last 12 quarters
- Price: $186.09 (+13.5% in a year)
- P/BV: 2.8× (higher than 87% of the last 5.3 years)
- Revenue (Sep 2026): $20.2 B (+10.8% on a year ago)
- Profit (Sep 2026): $5.0 B (+6.7% on a year ago)
- Net margin: 24.6% (−0.9 points on a year ago)
- ROE: 18%, FY25
- ROA: 1.34%, latest

The main question: results are strong, and the P/BV is higher than 87% of its own history. ## What is the Morgan Stanley share price today? Morgan Stanley's share price was $186.09 at the close on 3 November 2026. It has been moving sideways for 6 weeks. That is 4.2% below its average price over the last 200 trading days. In the last 52 weeks it traded between $155 and $223, and at that close it sat 46% of the way up from that low. Over the past 13 weeks it has done worse than the S&P 500, and it has been behind for 10 weeks running. Over the last 10 years the share price moved +606% while the S&P 500 moved +255%, so it is ahead of the index over that whole period. It was last ahead over 13 weeks in the week of 28 August 2026. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What dividend does Morgan Stanley pay? Morgan Stanley paid $4.38 per share over the last four reported quarters. The most recent declaration was $1.15 for Sep 2026. At today's price of $186.09 that is a yield of 2.35%, based on dividends already paid, not a forecast. ## Which stock lists is Morgan Stanley on? Morgan Stanley is on one of our US lists: S&P 500 companies. [S&P 500 companies](https://www.sectoralpha.in/sp-500-stocks)

## Is Morgan Stanley profitable? Morgan Stanley earned $5.0 B of net profit in the Sep 2026 quarter, +6.7% on the same quarter a year earlier. That is the 11th quarter in a row of profit growth. Full-year FY25 profit was $17.0 B. Over 4 years profit has grown 3.0% a year on average. That is 24.6% of the quarter's revenue. The same quarter a year earlier earned $4.7 B. For the full year, FY25 profit was $17.0 B (+25.8% on the year before). Why profit moved: revenue changed +10.8% on a year earlier and the margin moved −0.9 percentage points. Sales did the work, and the margin was about flat. On average over the last four quarters, profit changed +28.2% and revenue +16.5%. Profit is growing faster than sales: fixed costs are spread over more sales, so each extra dollar of revenue adds more to profit. ## How much revenue does Morgan Stanley make, and is it growing? Morgan Stanley reported $20.2 B of income in the Sep 2026 quarter, +10.8% on the same quarter a year earlier. That is the 12th quarter in a row with growth on the year before. Over 4 years it has grown 4.1% a year on average. The last full year, FY25, came in at $70.3 B. The last four reported quarters add to $79.8 B. FY25 revenue was $70.3 B, +14.3% on the year before. Recent pace: the last four quarters grew +16.5% on average, against 4.1% a year over the longer run, so this year is growing faster than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +16.4%, against +17.0% a year over the last 8 quarters (stabilising); profit over the last 12 months grew +26.7%, against +35.0% a year (rolling over). ## How much does Morgan Stanley keep from what it earns? Morgan Stanley's net margin was 24.6% in the Sep 2026 quarter, 0.9 percentage points lower than the same quarter a year ago. Across 5 years it has been between 17.2% and 25.3%. The latest quarter is within that range. Why: the net margin move is clear, but the cost details behind it are not in our data, so we show the move without guessing the reason. ## How many of Morgan Stanley's loans have gone bad? Morgan Stanley does not report loan-quality figures this page can read, so this section says so rather than guess. No bad-loan figures are filed in a form this page can read, and none are guessed from the profit line. The income, margin and return sections carry what this business does report. Why: loan quality drives a lender, but its details (new bad loans, recoveries, money set aside) are not in our data for this company. The sections around this one carry what we can back up. ## How fast is Morgan Stanley's loan book growing? Morgan Stanley's revenue was $70.3 B in FY25, +14.3% on the year before, so the loan book is growing. The latest quarter was +10.8% on a year earlier. The net margin on that income is 24.6%, −0.9 percentage points on a year ago. Interest income stands in for the size of the loan book; changes in interest rates can move it a few points in any year. In short: a lender grows well when its loan book grows, its margin stays steady and its loans stay clean. Quarterly loan-quality figures are missing here, so revenue growth and margin are the two we watch. ## What is Morgan Stanley's P/BV ratio, and how does it compare with its own history? Morgan Stanley's P/BV is 2.8×, near the high end of its own history: higher than 87% of past readings. Its usual P/BV (the middle reading) is 1.8×, over 5.3 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. Why the multiple is where it is: over the past year book value grew while the price moved +13.5%. The price ran ahead of book value, which pushed the multiple up within its own range. Where the price move came from: over 5 years the price moved +13.3% a year; about +4.4% a year came from book-value growth and about +8.9 percentage points from the multiple (the market paying more). The split is approximate (price return minus book-value growth). It shows how much of the move came from the market paying a different multiple. In short: the multiple is high against its own past, so the book value trend underneath matters more than the multiple. ## Is the Morgan Stanley business getting better or worse? Morgan Stanley's business is growing steadily. Revenue, profit and EPS growth have stayed positive throughout, and ROE is steady at 17.6%. This is based on 12 quarters of 4 measures. Why it matters: steady growth with healthy returns is how a business compounds over time. ## How much does Morgan Stanley earn on its equity and assets? Morgan Stanley earned a return on equity of 15% in FY25. Its lowest yearly reading on file was 9% in FY23. On its assets, every $100 earned about $1.34, before the effect of borrowing. For a lender the balance sheet is the business, so the return on equity and on assets have to be read together. That is above the level a bank needs to grow its net worth steadily. Why ROE moved: profit grew 3.0% a year over 4 years while net worth grew more slowly. When earnings recover faster than net worth builds up, ROE climbs off its low. ## Does Morgan Stanley have too much debt? For a bank, borrowing is the raw material of the business, not a warning sign: it borrows money in order to lend it out. Its safety is read through its returns and its loans. Its safety is read from the bad-loan figures and the return on equity instead. For a manufacturer, debt is a claim on its profits. For a lender it is the stock it trades in, so the usual debt-to-equity test would mislead and is not used here. ## What is the Morgan Stanley shareholding pattern? 0.0% of Morgan Stanley's tradable shares are in short positions, which are bets that the price will fall, so very few traders are betting against this stock. At normal trading volumes, closing those positions would take about 2.9 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead. It is a single reading at one point in time; we do not have its history. Why it is at this level: the figure does not say who holds the short positions or why, so we show the level without guessing the story. ## How far is Morgan Stanley from balance-sheet trouble? For Morgan Stanley, the Z-score is not used, because it was built for manufacturers, not lenders. For a lender, safety is read from its capital and bad-loan figures instead. ## How does Morgan Stanley rank in its industry? 57.3 out of 100, rank 11 of 28 in Capital Markets, with 80% of the evidence available. Morgan Stanley scores 57.3 out of 100 against the 28 companies it is compared with in Capital Markets, ranking 11. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 20.5 + 14.3 + 12.3 + 10.2 = 57.3. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if ROA turns down or gross NPA rises while the share price lags its sector. ## Which companies is Morgan Stanley compared with? Morgan Stanley ranks 11 of 28 Capital Markets companies on the 4-Factor Sector Score, with 57.3 out of 100. 1. [Virtu Financial, Inc.](https://www.sectoralpha.in/us/stocks/virt) VIRT · quiet · Most evidence points up · 76% evidence 75.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 25.5/35 · Income 24.7% · Profit 37.3% · 71% evidence Capital efficiency 18.7/25 · ROA 6.1% · ROE 66.5% · GNPA n/a · 68% evidence Valuation 16.5/20 · P/BV 2.23× · P/BV÷ROE 0.03 · 70% evidence Relative strength 15.0/20 · Lead over its industry 14% · Lead over S&P 500 5% · 1 year 50.6% · 100% evidence · 3 of 12 weeks ahead Exact sum: 25.5 + 18.7 + 16.5 + 15 = 75.7 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 2. [Evercore Inc.](https://www.sectoralpha.in/us/stocks/evr) EVR · basing · Most evidence points up · 76% evidence 73.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 28.4/35 · Income 45.4% · Profit 61.6% · 71% evidence Capital efficiency 20.4/25 · ROA 26.7% · ROE 58.6% · GNPA n/a · 68% evidence Valuation 13.3/20 · P/BV 6.06× · P/BV÷ROE 0.1 · 70% evidence Relative strength 11.5/20 · Lead over its industry -3.9% · Lead over S&P 500 -11.4% · 1 year -3% · 100% evidence · 0 of 12 weeks ahead Exact sum: 28.4 + 20.4 + 13.3 + 11.5 = 73.6 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 3. [BGC Group, Inc.](https://www.sectoralpha.in/us/stocks/bgc) BGC · turning · Most evidence points up · 76% evidence 70.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 24.0/35 · Income 27.8% · Profit 29.4% · 71% evidence Capital efficiency 17.7/25 · ROA 6.5% · ROE 27.6% · GNPA n/a · 68% evidence Valuation 10.7/20 · P/BV 4.02× · P/BV÷ROE 0.15 · 70% evidence Relative strength 17.6/20 · Lead over its industry 10% · Lead over S&P 500 1.5% · 1 year 20.5% · 100% evidence · 3 of 12 weeks ahead Exact sum: 24 + 17.7 + 10.7 + 17.6 = 70 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 4. [Marex Group Limited](https://www.sectoralpha.in/us/stocks/mrx) MRX · turning · Most evidence points up · 76% evidence 69.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 19.8/35 · Income 10% · Profit 60.4% · 71% evidence Capital efficiency 15.1/25 · ROA 1.3% · ROE 34.4% · GNPA n/a · 68% evidence Valuation 16.1/20 · P/BV 2.35× · P/BV÷ROE 0.07 · 70% evidence Relative strength 18.6/20 · Lead over its industry 33.1% · Lead over S&P 500 22.7% · 1 year 103.9% · 100% evidence · 10 of 12 weeks ahead Exact sum: 19.8 + 15.1 + 16.1 + 18.6 = 69.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 5. [Tradeweb Markets Inc.](https://www.sectoralpha.in/us/stocks/tw) TW · breaking out · Most evidence points up · 76% evidence 66.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.1/35 · Income 14.1% · Profit 60.6% · 71% evidence Capital efficiency 15.7/25 · ROA 10.5% · ROE 13.1% · GNPA n/a · 68% evidence Valuation 7.7/20 · P/BV 2.89× · P/BV÷ROE 0.22 · 70% evidence Relative strength 19.5/20 · Lead over its industry 18.1% · Lead over S&P 500 9.3% · 1 year 15.2% · 100% evidence · 6 of 12 weeks ahead Exact sum: 23.1 + 15.7 + 7.7 + 19.5 = 66 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 6. [PJT Partners Inc.](https://www.sectoralpha.in/us/stocks/pjt) PJT · basing · Evidence leans up · 76% evidence 62.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 21.2/35 · Income 22.7% · Profit 25% · 71% evidence Capital efficiency 20.0/25 · ROA 21% · ROE 36.8% · GNPA n/a · 68% evidence Valuation 13.4/20 · P/BV 3.96× · P/BV÷ROE 0.11 · 70% evidence Relative strength 8.0/20 · Lead over its industry -4.7% · Lead over S&P 500 -12.1% · 1 year -12.1% · 100% evidence · 3 of 12 weeks ahead Exact sum: 21.2 + 20 + 13.4 + 8 = 62.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 7. [Interactive Brokers Group, Inc.](https://www.sectoralpha.in/us/stocks/ibkr) IBKR · quiet · Evidence leans up · 80% evidence 62.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 18.7/35 · Income 17.9% · Profit 28.4% · 81% evidence Capital efficiency 16.8/25 · ROA 2.3% · ROE 24.6% · GNPA n/a · 68% evidence Valuation 16.5/20 · P/BV 1.67× · P/BV÷ROE 0.07 · 70% evidence Relative strength 10.3/20 · Lead over its industry 1.3% · Lead over S&P 500 -6.6% · 1 year 9.8% · 100% evidence · 3 of 12 weeks ahead Exact sum: 18.7 + 16.8 + 16.5 + 10.3 = 62.3 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 8. [The Goldman Sachs Group, Inc.](https://www.sectoralpha.in/us/stocks/gs) GS · quiet · Evidence leans up · 80% evidence 61.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 24.7/35 · Income 23.9% · Profit 34.6% · 81% evidence Capital efficiency 13.7/25 · ROA 1.3% · ROE 21.4% · GNPA n/a · 68% evidence Valuation 14.8/20 · P/BV 2.18× · P/BV÷ROE 0.1 · 70% evidence Relative strength 8.6/20 · Lead over its industry -1% · Lead over S&P 500 -8.8% · 1 year 14% · 100% evidence · 0 of 12 weeks ahead Exact sum: 24.7 + 13.7 + 14.8 + 8.6 = 61.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 9. [Piper Sandler Companies](https://www.sectoralpha.in/us/stocks/pipr) PIPR · basing · Evidence leans up · 76% evidence 60.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 27.7/35 · Income 32.4% · Profit 100% · 71% evidence Capital efficiency 17.3/25 · ROA 11.6% · ROE 17.4% · GNPA n/a · 68% evidence Valuation 9.4/20 · P/BV 3.12× · P/BV÷ROE 0.18 · 70% evidence Relative strength 5.8/20 · Lead over its industry -13.4% · Lead over S&P 500 -20.2% · 1 year -19.3% · 100% evidence · 0 of 12 weeks ahead Exact sum: 27.7 + 17.3 + 9.4 + 5.8 = 60.2 · What this means: Earnings are strong; relative strength in its sector is -13.4% and the one-year return is -19.3%. 10. [StoneX Group Inc.](https://www.sectoralpha.in/us/stocks/snex) SNEX · quiet · Evidence leans up · 76% evidence 59.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 25.2/35 · Income 20.4% · Profit 77.7% · 71% evidence Capital efficiency 15.6/25 · ROA 1.4% · ROE 26.7% · GNPA n/a · 68% evidence Valuation 12.4/20 · P/BV 3.3× · P/BV÷ROE 0.12 · 70% evidence Relative strength 6.2/20 · Lead over its industry -4.3% · Lead over S&P 500 -12% · 1 year 42.2% · 100% evidence · 0 of 12 weeks ahead Exact sum: 25.2 + 15.6 + 12.4 + 6.2 = 59.4 · What this means: Earnings are strong; relative strength in its sector is -4.3% and the one-year return is 42.2%. 11. Morgan Stanley this page MS · quiet · Evidence leans up · 80% evidence 57.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.5/35 · Income 16.4% · Profit 26.7% · 81% evidence Capital efficiency 14.3/25 · ROA 1.4% · ROE 19.4% · GNPA n/a · 68% evidence Valuation 12.3/20 · P/BV 2.52× · P/BV÷ROE 0.13 · 70% evidence Relative strength 10.2/20 · Lead over its industry 1.4% · Lead over S&P 500 -6.5% · 1 year 14.6% · 100% evidence · 0 of 12 weeks ahead Exact sum: 20.5 + 14.3 + 12.3 + 10.2 = 57.3 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 12. [MarketAxess Holdings Inc.](https://www.sectoralpha.in/us/stocks/mktx) MKTX · losing its lead · Evidence leans up · 80% evidence 57.2 out of 100 Growth Capital Valuation Relative
13. [Jefferies Financial Group Inc.](https://www.sectoralpha.in/us/stocks/jef) JEF · basing · Evidence leans up · 80% evidence 56.5 out of 100 Growth Capital Valuation Relative
14. [The Charles Schwab Corporation](https://www.sectoralpha.in/us/stocks/schw) SCHW · quiet · Evidence leans up · 80% evidence 56.0 out of 100 Growth Capital Valuation Relative
15. [Stifel Financial Corp.](https://www.sectoralpha.in/us/stocks/sf) SF · quiet · Evidence leans up · 80% evidence 54.5 out of 100 Growth Capital Valuation Relative
16. [Figure Technology Solutions, Inc.](https://www.sectoralpha.in/us/stocks/figr) FIGR · quiet · Evidence leans up · 70% evidence 50.0 out of 100 Growth Capital Valuation Relative
17. [Bitmine Immersion Technologies, Inc.](https://www.sectoralpha.in/us/stocks/bmnr) BMNR · breaking out · Too little evidence to rank firmly · 55% evidence 47.0 out of 100 Growth Capital Valuation Relative
18. [LPL Financial Holdings Inc.](https://www.sectoralpha.in/us/stocks/lpla) LPLA · quiet · Evidence leans down · 76% evidence 45.8 out of 100 Growth Capital Valuation Relative
19. [XP Inc.](https://www.sectoralpha.in/us/stocks/xp) XP · quiet · Evidence leans down · 76% evidence 45.7 out of 100 Growth Capital Valuation Relative
20. [Galaxy Digital Inc.](https://www.sectoralpha.in/us/stocks/glxy) GLXY · basing · Too little evidence to rank firmly · 55% evidence 45.7 out of 100 Growth Capital Valuation Relative
21. [Houlihan Lokey, Inc.](https://www.sectoralpha.in/us/stocks/hli) HLI · turning · Evidence leans down · 76% evidence 44.4 out of 100 Growth Capital Valuation Relative
22. [Moelis & Company](https://www.sectoralpha.in/us/stocks/mc) MC · basing · Evidence leans down · 76% evidence 43.2 out of 100 Growth Capital Valuation Relative
23. [Robinhood Markets, Inc.](https://www.sectoralpha.in/us/stocks/hood) HOOD · basing · Evidence leans down · 76% evidence 40.9 out of 100 Growth Capital Valuation Relative
24. [Circle Internet Group, Inc.](https://www.sectoralpha.in/us/stocks/crcl) CRCL · breaking out · Too little evidence to rank firmly · 59% evidence 34.0 out of 100 Growth Capital Valuation Relative
25. [TeraWulf Inc.](https://www.sectoralpha.in/us/stocks/wulf) WULF · basing · Too little evidence to rank firmly · 55% evidence 33.2 out of 100 Growth Capital Valuation Relative
26. [Riot Platforms, Inc.](https://www.sectoralpha.in/us/stocks/riot) RIOT · quiet · Too little evidence to rank firmly · 55% evidence 30.8 out of 100 Growth Capital Valuation Relative
27. [Hut 8 Corp.](https://www.sectoralpha.in/us/stocks/hut) HUT · quiet · Most evidence points down · 64% evidence 29.0 out of 100 Growth Capital Valuation Relative
28. [IREN Limited](https://www.sectoralpha.in/us/stocks/iren) IREN · quiet · Most evidence points down · 64% evidence 26.9 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. Financial companies use P/BV÷ROE and asset quality; PEG, industrial OPM and ROCE are excluded. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led S&P 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Capital Markets](https://www.sectoralpha.in/us/sectors/capital-markets), all 28 compared on one page. ## Which companies are close to Morgan Stanley in size? Morgan Stanley is the largest of 53 Capital Markets companies on Sector Alpha by market value (scores of 3 November 2026). It is the largest. Just below it: The Goldman Sachs Group, Inc., The Charles Schwab Corporation, Robinhood Markets, Inc., Interactive Brokers Group, Inc., Tradeweb Markets Inc. and Nomura Holdings, Inc. ### Capital Markets companies close in size

1. Morgan Stanley $291.2 billion
2. [The Goldman Sachs Group, Inc.](https://www.sectoralpha.in/us/stocks/gs) $271.3 billion
3. [The Charles Schwab Corporation](https://www.sectoralpha.in/us/stocks/schw) $154.4 billion
4. [Robinhood Markets, Inc.](https://www.sectoralpha.in/us/stocks/hood) $77.2 billion
5. [Interactive Brokers Group, Inc.](https://www.sectoralpha.in/us/stocks/ibkr) $35.1 billion
6. [Tradeweb Markets Inc.](https://www.sectoralpha.in/us/stocks/tw) $29.2 billion
7. [Nomura Holdings, Inc.](https://www.sectoralpha.in/us/stocks/nmr) $27.5 billion

[All 53 Capital Markets companies, largest first](https://www.sectoralpha.in/us/sectors/capital-markets#all-companies)

### Companies close in size in other industries

1. [Applied Materials, Inc.](https://www.sectoralpha.in/us/stocks/amat) $297.2 billion · Semiconductor Equipment & Materials
2. [HSBC Holdings plc](https://www.sectoralpha.in/us/stocks/hsbc) $294.7 billion · Banks - Diversified
3. Morgan Stanley $290.7 billion
4. [Shell plc](https://www.sectoralpha.in/us/stocks/shel) $289.7 billion · Oil & Gas Integrated
5. [AstraZeneca PLC](https://www.sectoralpha.in/us/stocks/azn) $288.3 billion · Drug Manufacturers - General

## What else do people ask about Morgan Stanley? ### What is Morgan Stanley's stock price today? Morgan Stanley's stock price is $186.09, +13.5% over the past year. The whole company is worth $291 B on the market. In the last 52 weeks it traded between $155 to $223; today it is 46% of the way up from the low, 4.2% below its 200-day average (as of 3 November 2026). ### What were Morgan Stanley's latest quarterly results? Morgan Stanley reported total income of $20.2 B and net profit of $5.0 B for the Sep 2026 quarter. Income rose 10.8% and profit rose 6.7% compared with a year earlier. Earnings per share were $3.03. The net margin was 24.6%, 0.9 percentage points lower than a year earlier (as of 3 November 2026). ### What is Morgan Stanley's market cap? Morgan Stanley's market capitalisation is $291 B at a stock price of $186.09. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is Morgan Stanley performing? Morgan Stanley's share price has been moving sideways for 6 weeks. In its latest quarter, income rose 10.8% and profit rose 6.7% compared with a year earlier. Over the past 13 weeks it has done worse than the S&P 500, for 10 weeks running (as of 3 November 2026). ### Will Morgan Stanley's stock price go up? This page does not forecast Morgan Stanley's stock price. What it shows instead: the stock price is $186.09, and it has been moving sideways for 6 weeks. Its P/BV of 2.8× is higher than 87% of its own last 5 years (as of 3 November 2026). ### Where is Morgan Stanley in its business cycle? Morgan Stanley's FY25 net margin was 24.2%, against a 5-year range of 17.2% to 25.3%: the middle of its own range, neither a peak nor a low. The latest quarter was 24.6%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the Morgan Stanley story? The main question: results are strong, and the P/BV is higher than 87% of its own history. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is Morgan Stanley a stock worth studying right now? What the numbers show: Morgan Stanley's earnings have grown faster than its share price. Earnings per share grew +28.4% in a year while the price moved +13.5%. The main open question: whether earnings grow enough to match the multiple. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). ## Lists

- S&P 500 companies: https://www.sectoralpha.in/sp-500-stocks

This is research, not advice. We’re not SEBI-registered.